The advancement of molecular technology has led to genomic and molecular profiling of UTUC by identifying various genetic alterations, such as mutations in FGFR3, TERT promoter and chromatin remodeling genes, which have potential implications for both diagnosis and treatment [27]. Here, FGFR3 is linked to renal pelvis/ureter urothelial carcinoma.